Skip to main content
All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company

 Filing Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 3, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California

Official filing document

 Lobbyists on this filing 4
  • LAUREN ALEXANDRA MISH New on this filing
    Previously held: Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs
  • EMILY FELDER New on this filing
    Previously held: Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
  • ADAM STEINMETZ New on this filing
    Previously held: Policy Advisor - Committee on the Budget, United States House of Representatives
  • STEPHEN HOLLAND New on this filing
    Previously held: Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 1
Health Issues

Outreach regarding cell therapies for autoimmune diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem